Perindopril-Indapamid-Mepha 10 mg / 2.5 mg

Perindopril-Indapamid-Mepha 10 mg / 2.5 mg is a medicine authorised by Swissmedic under authorisation number 66142. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 March 2017 and the authorisation is valid without a time limit. ATC code C09BA04 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 66142
  • ATC C09BA04
  • Synthetic medicines
Authorisation data
Authorisation number66142
NamePerindopril-Indapamid-Mepha 10 mg / 2.5 mg
Full namePerindopril-Indapamid-Mepha 10 mg / 2.5 mg, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09BA04
First authorisation01 March 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
3Perindopril-Indapamid-Mepha 10 mg / 2.5 mg, FilmtablettenB01 March 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)C09BA0402.07.2.B
290Tablette(n)C09BA0402.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Perindopril-Indapamid-Mepha 10 mg / 2.5 mg authorised in Switzerland?

Yes. Perindopril-Indapamid-Mepha 10 mg / 2.5 mg is authorised by Swissmedic under authorisation number 66142, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Perindopril-Indapamid-Mepha 10 mg / 2.5 mg have?

Perindopril-Indapamid-Mepha 10 mg / 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Perindopril-Indapamid-Mepha 10 mg / 2.5 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com